Richo and Jones interviews Clive Palmer; thanks him for his generous hydroxychloroquine donation to the nation
Watch the video“Clive, we’re very grateful.” In an interview with Clive Palmer, Alan Jones teases
29/04/2020 9:11 pm
Latest News
A Doctor's Story
Dr. Peter McCullough’s Common Sense Breakdown of the Pandemic – The Chloroquine Wars Part XXIII
McCullough walks through a thorough (if basic) coverage of many drugs and nutraceuticals that have been effectively used around the world—the best single such coverage seen packed into one video.
27/05/2021
Global
Five RCTs recently published in mainstream scientific journals that confirm major, statistically significant benefits of ivermectin against COVID-19
Major benefits of ivermectin (IVM) treatment for COVID-19 have been known since the results of 20 such randomized controlled trials (RCTs) were reported
26/05/2021
Ivermectin
Jamaican Doctors Fighting for Ivermectin While the Chief Medical Officer and Ministry of Health Ignores It
In our carefully considered opinion, the available data on Ivermectin is quite adequate. There is no need to await the outcome of further trials. Any call for local trials prior to approval is unnecessary, as neither time, resources, nor ethical approval would permit.
26/05/2021
A Doctor's Story
1st International Ivermectin for Covid Summit – Part 2
TrialSite hosted the first international Ivermectin for Covid Summit webinar on Sunday, May 23rd 2021. The event was widely attended with medical experts presenting from around the world to a global audience of interested parties in the thousands.
24/05/2021
Finland
Finnish firm earns US patent for Covid drug containing ivermectin and hydroxychloroquine
“Tackling the pandemic probably requires, in addition to a vaccine, a preventive or early-acting drug. This drug also helps especially in a situation where vaccine coverage threatens to remain too low for herd immunity,” said Väänänen.
24/05/2021
A Doctor's Story
1st International Ivermectin for Covid Summit – Part 1
TrialSite hosted the first international Ivermectin for Covid Summit webinar on Sunday, May 23rd 2021. The event was widely attended with medical experts presenting from around the world to a global audience of interested parties in the thousands.
24/05/2021
A Doctor's Story
Covid-19, Early Treatment, and America’s Frontline Doctors – The Dr Urso Interview
A medical doctor and scientist, Dr Urso is one of the most prominent C19 doctors in the US. Since March 2020, he has treated hundreds of patients at home, on an ambulatory basis. In this interview, he tells us about his experience, about C19 in Texas and about the America’s Frontline Doctors movement.
23/05/2021
Clinical Trials
Ivermectin Added to University of Minnesota COVID-19 Drug Trial
Leading the national trial is Dr. Carolyn Bramante, a U internal medicine specialist. Emphasizing the importance of this trial, she says, “Not everybody has access to the vaccine, whereas these medications are existing generics, already FDA-approved, that are available in most pharmacies around the world.” Dr. Bramante continued, “If we find evidence of benefit, [the drugs] could be used immediately anywhere.”
23/05/2021
A Doctor's Story
Hydroxychloroquine is the smartest drug in history
Dr Richard Urso uncovers a hugely significant detail in a chloroquine study. Chloroquine will protect a normal cell & let the virus attack a cancer cell.
21/05/2021
About The Foundation
The Palmer Foundation is the philanthropic entity owned by the Palmer family, headed by Clive Palmer.
The Palmer Foundation is a private entity that engages in charitable projects that enable better welfare of others, and society as a whole.
The foundations most recent endeavour revolves around the response to, and action on the COVID-19 Virus pandemic for the treatment of all Australians in need.
Click here to get the background on The Palmer Foundations COVID-19 Response.
Share on facebook
Share on twitter
Share on whatsapp
On Trend
Popular Stories
France
Institut Pasteur Preclinical Study: Ivermectin a Powerful Immunomodulatory Drug Targeting SARS-CoV-2
The French scientists concluded, “This study supports the use of immunomodulatory drugs such as ivermectin, to improve the clinical condition of SARS-CoV-infected patients.”
14/07/2021
Ivermectin
Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin
Altogether, this study brings the proof of concept that an IVM-based immunomodulatory therapy improves the clinical condition of SARS-CoV-2-infected hamsters, and in clinical trials, it alleviates symptoms of COVID-19 in humans and possibly limits post-COVID-19 syndrome (also known as long COVID) via an anti-inflammatory action.
12/07/2021
Azithromycin
A Conversation With Dr. Brian Tyson – The Chloroquine Wars Part XLI
The data from the vaccine trials must be recalculated under the lens that some of the serious adverse events (SAEs) should be treated as COVID-19 cases.
There may not be any vaccine efficacy in the data at all if some of the post-vaccination deaths are due to vaccine-induced COVID-19. It could even be the case that the mortality efficacy goes negative. My implied lives saved calculations put this easily in the realm of possibility. The only way to know is for authorities to organize and compile the data. And while a risk analysis is certainly due after more than six months of hundreds of millions of doses delivered, there is little indication authorities have bothered with the process. That’s more than a bit unsettling.
05/07/2021
Hydroxychloroquine
Dr. Brian Tyson, USA: Hydroxychloroquine – Data, Strategies and Success Treating over 6000 Covid Patients
We continue to delve extensively into the COVID-19 data with esteemed statistician, Mathew Crawford. In this episode, we take a closer look at the use of early treatment and its success. Mathew has been researching the data from Dr. Brian Tyson, who has successfully treated over 6000 patients who contracted COVID throughout the pandemic. It is my great honor to have Dr. Tyson here on this episode to not only discuss the data, but also the strategies that he has been using throughout the pandemic.
03/07/2021